Gene expression profile and pathogenicity of biofilm-forming Prevotella intermedia strain 17

BMC Microbiology

Volumn 9, Issue , 2009, Pages

  Yamanaka, Takeshi ^a   Furukawa, Tomoyo ^a   Matsumoto Mashimo, Chiho ^a   Yamane, Kazuyoshi ^a   Sugimori, Chieko ^a   Nambu, Takayuki ^a   Mori, Naoki ^a   Nishikawa, Hiroyuki ^a   Walker, Clay B ^b   Leung, Kai Poon ^c   Fukushima, Hisanori ^a  

^a OSAKA DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN;

ANIMAL; ARTICLE; BACTEROIDACEAE INFECTION; BAGG ALBINO MOUSE; BIOFILM; CELL CULTURE; CHEMISTRY; CHRONIC PERIODONTITIS; CULTURE MEDIUM; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; MONONUCLEAR CELL; MOUSE; PATHOGENICITY; PHAGOCYTOSIS; PHYSIOLOGY; PREVOTELLA INTERMEDIA; VIRULENCE;

ANIMALS; BACTERIAL PROTEINS; BACTEROIDACEAE INFECTIONS; BIOFILMS; CELLS, CULTURED; CHRONIC PERIODONTITIS; CULTURE MEDIA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHAGOCYTOSIS; POLYSACCHARIDES, BACTERIAL; PREVOTELLA INTERMEDIA; VIRULENCE;

EID: 60149112757     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-9-11     Document Type: Article

References (63)

1. Dental biofilms: difficult therapeutic targets. SS Socransky AD Haffajee, Periodontol 2000 2002 28 12 55 10.1034/j.1600-0757.2002.280102.x 12013340
2. Microbiological understandings and mysteries of noma (cancrum oris). WA Falkler Jr CO Enwonwu EO Idigbe, Oral Dis 1999 5 2 150 155 10522213
3. Experimental gingivitis during pregnancy and post-partum: clinical, endocrinological, and microbiological aspects. JE Raber-Durlacher TJ van Steenbergen U Van der Velden J de Graaff L Abraham-Inpijn, J Clin Periodontol 1994 21 8 549 558 10.1111/j.1600-051X.1994.tb01172.x 7989619
4. Localization and identification of root canal bacteria in clinically asymptomatic periapical pathosis. H Fukushima K Yamamoto K Hirohata H Sagawa K-P Leung C Walker, J Endod 1990 16 11 534 8 2084210
5. Association of black-pigmented bacteria with endodontic infections. JC Baumgartner BJ Watkins KS Bae T Xia, J Endod 1999 25 6 413 415 10.1016/S0099-2399(99)80268-4 10530240
6. Microbiology of intracranial abscesses associated with sinusitis of odontogenic origin. I Brook, Ann Otol Rhinol Laryngol 2006 115 12 917 920 17214267
7. Purification and partial characterization of an elastolytic serine protease of Prevotella intermedia. Y Shibata S Fujimura T Nakamura, Appl Environ Microbiol 1993 59 7 2107 2111 8357246
8. Characterization of immunoglobulin G-degrading proteases of Prevotella intermedia and Prevotella nigrescens. HJ Jansen D Grenier JS Van der Hoeven, Oral Microbiol Immunol 1995 10 3 138 145 10.1111/j.1399-302X.1995.tb00134.x 7567062
9. Isolation, cloning, and expression of an acid phosphatase containing phosphotyrosyl phosphatase activity from Prevotella intermedia. X Chen T Ansai S Awano T Iida S Barik T Takehara, J Bacteriol 1999 181 22 7107 7114 10559178
10. Identification of a fimbriae-associated haemagglutinin from Prevotella intermedia. K-P Leung W Nesbitt M Okamoto H Fukushima, Microb Pathog 1999 26 139 148 10.1006/mpat.1998.0258 10089154
11. Chemical structure and immunobiological activity of lipid A from Prevotella intermedia ATCC 25611 lipopolysaccharide. M Hashimoto Y Asai R Tamai T Jinno K Umatani T Ogawa, FEBS Lett 2003 543 1-3 98 102 10.1016/S0014-5793(03) 00414-9 12753913
12. Phenotypic characteristics and DNA relatedness in Prevotella intermedia and similar organisms. H Fukushima H Moroi J Inoue T Onoe T Ezaki E Yabuuchi KP Leung CB Walker WB Clark H Sagawa, Oral Microbiol Immunol 1992 7 1 60 64 10.1111/j.1399-302X.1992.tb00023.x 1528627
13. Invasion of human oral epithelial cells by Prevotella intermedia. BR Dorn KL Leung A Progulske-Fox, Infect Immun 1998 66 12 6054 6057 9826397
14. +T cells. KP Leung BA Torres, Infect Immun 2000 68 5420 5424 10948175 10.1128/IAI.68.9.5420-5424.2000
15. The Institute for Genomic Research. http://cmr.tigr.org/tigr-scripts/CMR/ GenomePage.cgi?database=gpi
16. A novel exopolysaccharide from a clinical isolate of Prevotella nigrescens: purification, chemical characterization and possible role in modifying human leukocyte phagocytosis. K Yamane T Yamanaka N Yamamoto T Furukawa H Fukushima CB Walker KP Leung, Oral Microbiol Immunol 2005 20 1 1 9 10.1111/j.1399-302X.2004.00178.x 15612938
17. Center for Information Biology gene Expression database. http://cibex.nig.ac.jp/index.jsp
18. Bacterial biofilms: a common cause of persistent infections. JW Costerton PS Stewart EP Greenberg, Science 1999 284 5418 1318 1322 10.1126/science.284. 5418.1318 10334980
19. Understanding biofilm resistance to antibacterial agents. D Davies, Nat Rev Drug Discov 2003 2 2 114 122 10.1038/nrd1008 12563302
20. Survival strategies of infectious biofilms. CA Fux JW Costerton PS Stewart P Stoodley, Trends Microbiol 2005 13 1 34 40 10.1016/j.tim.2004.11.010 15639630
21. Biofilm, city of microbes. P Watnick R Kolter, J Bacteriol 2000 182 2675 2679 10781532 10.1128/JB.182.10.2675-2679.2000
22. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. C Ryder M Byrd DJ Wozniak, Curr Opin Microbiol 2007 10 6 644 648 17981495 10.1016/j.mib.2007.09.010
23. Structural elucidation of a novel exopolysaccharide produced by a mucoid clinical isolate of Burkholderia cepacia. Characterization of a trisubstituted glucuronic acid residue in a heptasaccharide repeating unit. S Cerantola A Lemassu-Jacquier H Montrozier, Eur J Biochem 1999 260 2 373 383 10.1046/j.1432-1327.1999.00171.x 10095771
24. The multicellular morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the second component of the extracellular matrix. X Zogaj M Nimtz M Rohde W Bokranz U Romling, Mol Microbiol 2001 39 6 1452 1463 10.1046/j.1365-2958.2001.02337.x 11260463
25. Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture. PN Danese LA Pratt R Kolter, J Bacteriol 2000 182 12 3593 3596 10852895 10.1128/JB.182.12.3593-3596.2000
26. The pga ABCD locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. X Wang JF Preston 3rd T Romeo, J Bacteriol 2004 186 9 2724 2734 15090514 10.1128/JB.186.9.2724-2734.2004
27. Developmental pathway for biofilm formation in curli-producing Escherichia coli strains: role of flagella, curli and colanic acid. C Prigent-Combaret G Prensier TT Le Thi O Vidal P Lejeune C Dorel, Environ Microbiol 2000 2 4 450 464 10.1046/j.1462-2920.2000.00128.x 11234933
28. Genetic analysis of Salmonella enteritidis biofilm formation: critical role of cellulose. C Solano B Garcia J Valle C Berasain J-M Ghigo C Gamazo I Lasa, Mol Microbiol 2002 43 3 793 808 10.1046/j.1365-2958.2002.02802.x 11929533
29. Vibrio cholerae O1 strain TSI-4 produces the exopolysaccharide materials that determine colony morphology, stress resistance, and biofilm formation. SN Wai Y Mizunoe A Takade S-I Kawabata S-I Yoshida, Appl Environ Microbiol 1998 64 10 3648 3655 9758780
30. Staphylococcus and biofilms. F Gotz, Mol Microbiol 2002 43 6 1367 1378 10.1046/j.1365-2958.2002.02827.x 11952892
31. Genes involved in formation of structured multicellular communities by Bacillus subtilis. SS Branda JE Gonzalez-Pastor E Dervyn SD Ehrlich R Losick R Kolter, J Bacteriol 2004 186 12 3970 3979 15175311 10.1128/JB.186.12.3970-3979. 2004
32. Purification and chemical characterization of an exopolysaccharide isolated from Capnocytophaga ochracea. JK Dyer RW Bolton, Can J Microbiol 1985 31 1 1 5 3986710
33. Modulation of in vitro human lymphocyte responses by an exopolysaccharide from Capnocytophaga ochracea. RW Bolton JK Dyer RA Reinhardt DK Okano, J Dent Res 1983 62 12 1186 1189 6581194
34. Antiphagocytic effect of slime from a mucoid strain of Pseudomonas aeruginosa. S Schwarzmann JR Boring III, Infect Immun 1971 3 762 767 16558051
35. Interaction between human polymorphonuclear leucocytes and bacteria released from in-vitro bacterial biofilm models. H Yasuda Y Ajiki J Aoyama T Yokota, J Med Microbiol 1994 41 5 359 367 7966209
36. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. C Vuong JM Voyich ER Fischer KR Braughton AR Whitney FR DeLeo M Otto, Cell Microbiol 2004 6 3 269 275 10.1046/j.1462-5822.2004.00367.x 14764110
37. Role of colanic acid polysaccharide in serum resistance in vivo and in adherence. AJ Lopez-Torres V Stout, Curr Microbiol 1996 33 6 383 389 10.1007/s002849900132 8900105
38. Virulence properties of Pseudomonas aeruginosa lacking the extreme- stress sigma factor AlgU (sigmaE). H Yu J Boucher N Hibler V Deretic, Infect Immun 1996 64 7 2774 2781 8698507
39. Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. AJ Jesaitis MJ Franklin D Berglund M Sasaki CI Lord JB Bleazard JE Duffy H Beyenal Z Lewandowski, J Immunol 2003 171 8 4329 4339 14530358
40. Virulence of Staphylococcus epidermidis in a mouse model: significance of extracellular slime. MA Deighton R Borland JA Capstick, Epidemiol Infect 1996 117 2 267 280 8870624
41. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. JG Leid ME Shirtliff JW Costerton AP Stoodley, Infect Immun 2002 70 11 6339 6345 12379713 10.1128/IAI.70.11.6339-6345.2002
42. Inflammatory pathways and microvascular responses in the lung. WM Kuebler, Pharmacol Rep 2005 57 Suppl 196 205 16415500
43. Neutrophil granule contents in the pathogenesis of lung injury. TJ Moraes JH Zurawska GP Downey, Curr Opin Hematol 2006 13 1 21 27 10.1097/01.moh. 0000190113.31027.d5 16319683
44. Why chronic wounds will not heal: a novel hypothesis. T Bjarnsholt K Kirketerp-Moller PO Jensen KG Madsen R Phipps K Krogfelt N Hoiby M Givskov, Wound Repair Regen 2008 16 1 2 10 10.1111/j.1524-475X.2007.00283.x 18211573
45. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. TS Walker KL Tomlin GS Worthen KR Poch JG Lieber MT Saavedra MB Fessler KC Malcolm ML Vasil JA Nick, Infect Immun 2005 73 6 3693 3701 15908399 10.1128/IAI.73.6.3693-3701.2005
46. Finding gene-expression patterns in bacterial biofilms. C Beloin JM Ghigo, Trends Microbiol 2005 13 1 16 19 10.1016/j.tim.2004.11.008 15639627
47. Prevotella intermedia native plasmid can be mobilized by an Escherichia coli conjugal IncP plasmid. KP Leung AS Lewis SP Concannon H Yoshimoto H Fukushima, Plasmid 2002 48 1 64 72 10.1016/S0147-619X(02)00011-2 12206757
48. Starting a new genetic system: lessons from bacteroides. AA Salyers G Bonheyo NB Shoemaker, Methods 2000 20 1 35 46 10.1006/meth.1999.0903 10610802
49. Microbial pathogenesis in cystic fibrosis: co-ordinate regulation of heat-shock response and conversion to mucoidy in Pseudomonas aeruginosa. MJ Schurr V Deretic, Mol Microbiol 1997 24 2 411 420 10.1046/j.1365-2958.1997. 3411711.x 9159526
50. Multiple promoters and induction by heat shock of the gene encoding the alternative sigma factor AlgU (sigma E) which controls mucoidy in cystic fibrosis isolates of Pseudomonas aeruginosa. M Schurr H Yu J Boucher N Hibler V Deretic, J Bacteriol 1995 177 19 5670 5679 7559357
51. GroEL1: A dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in Mycobacteria. A Ojha M Anand A Bhatt L Kremer J Jacobs R William GF Hatfull, Cell 2005 123 5 861 873 10.1016/j.cell.2005.09.012 16325580
52. Clp ATPases are required for stress tolerance, intracellular replication and biofilm formation in Staphylococcus aureus. D Frees A Chastanet S Qazi K Sorensen P Hill T Msadek H Ingmer, Mol Microbiol 2004 54 5 1445 1462 10.1111/j.1365-2958.2004.04368.x 15554981
53. A complex transcription network controls the early stages of biofilm development by Escherichia coli. BM Pruss C Besemann A Denton AJ Wolfe, J Bacteriol 2006 188 11 3731 3739 16707665 10.1128/JB.01780-05
54. Gene expression in Escherichia coli biofilms. D Ren LA Bedzyk SM Thomas RW Ye TK Wood, Appl Microbiol Biotechnol 2004 64 4 515 524 10.1007/s00253-003- 1517-y 14727089
55. Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa. AM Firoved V Deretic, J Bacteriol 2003 185 3 1071 1081 12533483 10.1128/JB.185.3.1071-1081.2003
56. Gene expression in Pseudomonas aeruginosa biofilms. M Whiteley MG Bangera RE Bumgarner MR Parsek GM Teitzel S Lory EP Greenberg, Nature 2001 413 6858 860 864 10.1038/35101627 11677611
57. CpxP, a stress-combative member of the Cpx regulon. PN Danese TJ Silhavy, J Bacteriol 1998 180 4 831 839 9473036
58. Sigma factors in Pseudomonas aeruginosa. E Potvin F Sanschagrin RC Levesque, FEMS Microbiol Rev 2008 32 1 38 55 18070067
59. Induction of a global stress response during the first step of Escherichia coli plate growth. C Cuny M Lesbats S Dukan, Appl Environ Microbiol 2007 73 3 885 889 17142356 10.1128/AEM.01874-06
60. Influence of origin of isolates, especially endocarditis isolates, and various genes on biofilm formation by Enterococcus faecalis. JA Mohamed W Huang SR Nallapareddy F Teng BE Murray, Infect Immun 2004 72 6 3658 3663 15155680 10.1128/IAI.72.6.3658-3663.2004
61. Quantitative studies of the specificity of anti-pneumococcal polysaccharide antibodies, types 3 and 8. II. Inhibition of precipitin reactions with oligosaccharides isolated from hydrolysates of S3 and S8. JH Campbell AM Pappenheimer Jr, Immunochemistry 1966 3 3 213 222 10.1016/0019-2791(66)90185-6 4381031
62. A nondegradative route for the removal of endotoxin from exopolysaccharides. O Adam A Vercellone F Paul PF Monsan G Puzo, Anal Biochem 1995 225 2 321 327 10.1006/abio.1995.1161 7762798
63. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. BM Bolstad RA Irizarry M Astrand TP Speed, Bioinformatics 2003 19 2 185 193 10.1093/bioinformatics/19.2.185 12538238